On July 19, Clean Science & Technology Specialty chemicals company opened its share price with a massive 98% premium.
Given its robust financial situation with leading industry return ratios, diversified products portfolios, a strong focus on environmental, social and corporate governance, consistent research and development initiatives and a solid customer base, the company has received positive results.
The stock price began at Rs 1784.40, higher than the issuing price of Rs 837 for BSE by Rs 884.40 or 98.27 percent. At 10:03 IST hours, it rated the volume of 6.38 lakh shares in Rs 1,606.85, up 70.85 or 78.54 percent over the issue price.
Specialty chemicals like performance chemicals and pharmaceutical intermediates, and FMCG chemicals are manufactured by Clean Science.
It is the only company worldwide to use vapor-phase technology to produce phenol Anisole with better atomic economy and water as a wastewater than the liquid-phase process.
The customers of the company include both direct end-use manufacturers and institutional distributors. The majority of the revenue of the company is generated by direct customer sales.
Some of the key customers of the company include Bayer and SRF, Gennex Laboratoires, and Vinati Bio products for specialty monomer products, Nutriad International NV, and Bayer AG.
For example, the company also provides products for the nutrition of animals. Rs 1,546.62 crore had been mobilised during its public debate on 7-9 July. These funds will be sold to shareholders because it was an offer to sell.
The Clean Science recorded revenues at a CAGR of 28%, the EBITDA of 52%, and the profit of 60% during FY18-FY 21 (earnings before interest, tax, depreciation and amortisation). Over the same period, the margin grew to 50.5% from 30.2%.